This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Jonathan Weissman
Introduction
Jonathan Weissman is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of epigenetic modifications. With a total of 2 patents, Weissman continues to push the boundaries of scientific innovation.
Latest Patents
Weissman's latest patents focus on compositions and methods for making epigenetic modifications. The disclosures provide, in various embodiments, fusion proteins comprising a DNA-binding domain, a DNMT3A-binding domain, and a H3K4me0. Additionally, the patents include polynucleotides and vectors encoding one or more of the fusion proteins. The disclosures also encompass gene-delivery systems, cells, compositions (e.g., pharmaceutical compositions), and kits comprising one or more of the fusion proteins, polynucleotides, or vectors. Furthermore, the methods outlined involve epigenetically modifying a genomic locus in a cell and treating a subject (e.g., a human) in need thereof.
Career Highlights
Jonathan Weissman is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work has garnered attention for its innovative approach to understanding and manipulating genetic material.
Collaborations
Some of Weissman's notable coworkers include Edwin Neumann and Tessa Bertozzi. Their collaborative efforts contribute to the advancement of research in the field of epigenetics.
Conclusion
Jonathan Weissman is a key figure in the realm of biomedical innovation, with a focus on epigenetic modifications. His patents and research continue to pave the way for new treatments and understanding of genetic processes.